Study of drug prescription pattern in ischemic heart disease patients
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20192644Keywords:
Anticoagulants, Antiplatelet, ACE inhibitors, Drug utilization, Hypolipidemics, Ischemic heart diseaseAbstract
Background: Drug utilization pattern studies helps to screen, assess and propose appropriate modifications in prescription practices, this would help to make patient care rational and cost effective. Study was intended to analyse the drug prescribing pattern for treatment of Ischemic heart disease using WHO indicators.
Methods: This is a cross sectional observational study conducted on ischemic heart disease patients admitted at inpatient department of medicine in a tertiary care teaching hospital. The study consisted of analysis of drug utilization pattern of prescribed drugs.
Results: IHD was more commonly seen in males (70.06%) than females (29.94%). IHD was most commonly seen in patients of age group of 61-70 year. Drugs prescribed to patients belong to various therapeutic classes ranging from anti-platelets, anticoagulants, anti-anginal, antithrombin, thrombolytic, hypolipidemics. The most commonly prescribed therapeutic class of drugs was antiplatelet (86.26%) followed by hypolipidemic (82.25%) and ACE inhibitors drugs (46.60%). Average number of drugs per encounter was 7.70. Drugs were prescribed by their generic names were 29.99%. Out of total study group 22.06% patients were prescribed at least one antibiotic. Injections were prescribed only in 1392 (27.86%) out of 4995 drugs. Of total drugs 3270 (65.45%) of drugs were from National List of Essential Medicines-2016 (NLEM -2016) and 2774 (55.53%) drugs prescribed were from WHO-EML-2016.
Conclusions: Risk of artery disease increased with increasing age. IHD was more common in males than females. The most commonly prescribed drug classes in Ischemic heart disease were anti-platelet drugs followed by hypolipidemic agents.
References
Antma EM, Selwyn AP, Loscalzo J. Ischemic Heart Disease. Harrison’s Principles of Internal Medicine. 18th ed. New York: McGraw-Hill; 2012:1998-2015.
World Health Organisation. Miscoding and misclassification of ischaemic heart disease mortality. World Health Organisation; 2001. Available at http://www.who.int/healthinfo/paper12.pdf. accessed 18 Feb 2017.
World Health Organisation. Fact Sheet. The top 10 causes of death. World Health Organisation; 2001. Available at http://www.who.int/mediacentre/factsheets/fs310/en/.
Gupta R, Mohan I, Narula J. Trends in Coronary Heart Disease Epidemiology in India. Ann Glob Heal Elsevier Inc. 2016;82(2):307-15.
Gupta R, Guptha S, Sharma KK, Gupta A, Deedwania PC. Regional variations in cardiovascular risk factors in India: India heart watch. World J Cardiol. 2012 26;4(4):112.
Gupta R, Mohan I, Narula J. Trends in coronary heart disease epidemiology in India. Ann Glob Heal Elsevier Inc. 2016;82(2):307-15.
World Health Organisation. The Pursuit of Responsible Use of Medicines. World Health Organisation; 2012. Available at http://www.who.int/medicines/areas/rational_use/en/. Accessed 26 Feb 2017.
World Health Organization (WHO) and International Network for Rational Use of Drugs, How to Investigate Drug Use in Health Facilities: Selected Drug Use indicators, WHO/DAP/93.1, WHO, Geneva, Switzerland, 1993. Available at http://apps.who.int/medicinedocs/pdf/s2289e/s2289e.pdf. Accessed 27 Feb 2017.
Hawkey CJ, Hodgson S, Norman A, Daneshmend TK, Garner ST. Effect of reactive pharmacy intervention on quality of hospital prescribing. BMJ. 1990 ;300(6730):986-90.
World Health Organization (WHO) International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology, WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services. Introduction to Drug utilization Research, WHO, Oslo, Norway, 2003. Available at http://apps.who.int/medicinedocs/pdf/s4876e/s4876e.pdf. Accessed 3 Mar 2017.
World Health Organization (WHO. Guidelines for ATC Classification and DDD assignment 2013. Available at https://www.whocc.no/filearchive/publications/1_2013guidelines.pdf. Accessed 3 Mar 2017.
Introduction to Drug Utilization Research. World Health Organization 2003. Available at http://apps.who.int/medicinedocs/pdf/s4876e/s4876e.pdf. Accessed 18 Feb 2017.
Nagabushan H, Roopadevi HS, Prakash GM, Pankaja R. A prospective study of drug utilization pattern in cardiac intensive care unit at a tertiary care teaching hospital. Inter J Basi Clin Pharma. 2017;4(3):579-83.
Sreedevi K, Rao JV, Fareedullah M, Vijayakumar S. A study on prescription pattern of statins in cardiovascular disease. Der Pharm Lett. 2011;3(3):393-6.
Dawalji S, Venkateshwarlu K, Thota S, Venisetty PK, Venisetty RK. Prescribing pattern in coronary artery disease: a prospective study. Int J Pharm Res Rev. 2014;3(3):24-33.
Tamilselvan T, Rajan H, Sabith T. A retrospective study of prescription pattern and cost analysis of selected drugs used in coronary artery disease and angioplasty patient. Inte J Rece Tren Sci Techno. 2016;21(1):09-12.
Shankar R, Partha P, Shenoy N. Prescribing patterns of drugs among patients admitted with cardiovascular disorders in the internal medicine ward: prescribing patterns in inpatients. Inte J Inter Med. 2000;3(1):1-5.
Sandozi T, Nausheen F. Drug utilization study in ischemic heart diseases associated with diabetes and hypertension. Int J Pharma Bio Sci. 2010;1(3):-4.
Christian RP, Rana DA, Malhotra SD, Patel VJ. Evaluation of rationality in prescribing, adherence to treatment guidelines, and direct cost of treatment in intensive cardiac care unit: a prospective observational study. Indian J Crit Care Med. 2014;18(5):278-84.
